Why these ASX 200 shares could surge in 2024
The first ASX 200 share earning a broker upgrade is medical device developer Polynovo Ltd (ASX: PNV).For its half-year results (1H FY 2024) Polynovo reported a 54.9% year on year increase in sales to $42.2 million. That represents a new half-year record for the healthcare stock.Meanwhile, revenue soared 65.6% from 1H FY 2023 to $48.8 million. And net profit after tax (NPAT) came in at $2.7 million, up from a loss of $3.8 million.The Polynovo share price closed down 1.7% yesterday. But investor sentiment has turned sharply bullish today, with Polynovo shares up 9.3% in afternoon trade at $2.17.Wilsons sees further upside potential even after that big boost. The broker raised Polynovo to an overweight rating with a $2.44 price target. That represents a potential 12% gain from current levels.
Posted via motley fool
- Forums
- ASX - By Stock
- PNV - Banter and General Comments
Why these ASX 200 shares could surge in 2024The first ASX 200...
-
- There are more pages in this discussion • 669 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.31 |
Change
-0.040(1.70%) |
Mkt cap ! $1.590B |
Open | High | Low | Value | Volume |
$2.32 | $2.34 | $2.29 | $681.6K | 295.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 35652 | $2.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.31 | 16087 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 52712 | 2.300 |
20 | 49914 | 2.290 |
21 | 110705 | 2.280 |
11 | 37501 | 2.270 |
10 | 50306 | 2.260 |
Price($) | Vol. | No. |
---|---|---|
2.310 | 5994 | 10 |
2.320 | 43454 | 23 |
2.330 | 37675 | 18 |
2.340 | 56418 | 16 |
2.350 | 15221 | 9 |
Last trade - 11.37am 10/07/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online